Sudarshan Sukhani of s2analytics.com told CNBC-TV18, "The call is to be up beat on Sun Pharmaceutical Industries which means every dip is a buying opportunity, even intraday dips. One of the reasons we did not suggest shorting Sun Pharmaceuticals even in the bad times was that it is an outstanding stock in terms of current performance. So, I would be upbeat. Pharmaceuticals and IT are the two safe havens."On Wednesday, Sun Pharmaceutical Industries closed at Rs 927.25, up Rs 38.40, or 4.32 percent. It has touched an intraday high of Rs 930.40 and an intraday low of Rs 894.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!